AI Article Synopsis
- Mesalamine is a widely used medication for treating Crohn's disease, but some patients can have allergic reactions to it.
- There is not much research on mesalamine-induced myocarditis, which is inflammation of the heart muscle, and the exact mechanism behind it is unclear.
- The text presents a case study documenting myocarditis caused by mesalamine in a patient with colon Crohn's disease.
Article Abstract
Nowadays mesalamine is a common treatment for Crohn's disease and hypersensitive reactions to this product have been reported. Yet there is limited information concerning mesalamine-induced myocarditis and its mechanism is not known. We described a case of mesalamine-induced myocarditis in Crohn's disease of the colon.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943131 | PMC |
| http://dx.doi.org/10.4061/2010/930190 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Recurrent Pericarditis: A Rare Adverse Effect of Mesalamine.
Cureus
January 2023
Internal Medicine, Bassett Medical Center, Cooperstown, USA.
Inflammation of the myocardium (myocarditis), pericardium (pericarditis), or both (myopericarditis) is a rare but potentially lethal side effect of mesalamine, a drug widely used in the treatment of inflammatory bowel disease (IBD). A 64-year-old female with a history of ulcerative colitis on mesalamine presented with dyspnea and chest pain. The patient was found to have mild to moderate pericardial effusion with signs of pericarditis.
View Article and Find Full Text PDFMesalamine-induced Myocarditis in a Young Athlete: Can He Run Again?
Cureus
January 2019
Cardiology, State University of New York at Buffalo, Buffalo, USA.
Mesalamine is often used in the treatment of inflammatory bowel disease (IBD). Mesalamine-induced cardiotoxicity has been reported in the literature and is a rare entity. The mechanism of cardiotoxicity remains unclear, however, it is believed to be due to a humoral-mediated hypersensitivity reaction.
View Article and Find Full Text PDFMesalamine-Induced Myopericarditis: A Case Report and Literature Review.
Cardiol Res
February 2019
Department of Internal Medicine, University of Nevada - Reno, School of Medicine, Reno, NV 89502, USA.
Inflammation of the myocardium (myocarditis) or pericardium (pericarditis) or both (myopericarditis) as side effects of mesalamine, a drug widely used in the treatment of inflammatory bowel disease, is a rare, but potentially lethal complication. We report a case of myopericarditis occurring in a young Caucasian woman 14 days following initiation of mesalamine therapy for treatment of a newly diagnosed ulcerative colitis (UC). She presented with pleuritic chest pain, elevated troponin levels and pre-syncope.
View Article and Find Full Text PDFMyocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative Colitis.
Case Rep Med
March 2018
Department of Internal Medicine, Section of Rheumatology, Virginia Tech Carilion School of Medicine and Research Institute, Raonoke, VA, USA.
Development of cardiac manifestations in patients diagnosed with inflammatory bowel disease undergoing treatment with mesalamine is a rare. When this occurs, it can be difficult to tease out the primary etiology, as both IBD and mesalamine can cause cardiac manifestations independently of each other. The exact mechanism of mesalamine-induced cardiotoxicity is yet to be determined although several mechanisms have been described.
View Article and Find Full Text PDFCardiac MRI-confirmed mesalamine-induced myocarditis.
BMJ Case Rep
September 2015
Department of Cardiology, Hartford Hospital, Hartford, Connecticut, USA.
A 38-year-old Caucasian man with a medical history significant for inflammatory bowel disease (IBD) and mesalamine use presented to the emergency department with stabbing, pleuritic, substernal chest pain over the previous 2 days. Findings of leucocytosis, elevated cardiac enzymes and inflammatory markers, T-wave or ST-segment abnormalities and left ventricular systolic dysfunction suggested mesalamine-induced myocarditis. However, a cardiac MRI confirmed the diagnosis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!